Patient Profile 1: A Patient With HER2+ Metastatic BC Treated With T-DXd who Develops ILD

Video

After reviewing the historical use of ADCs, panelists discuss the first patient profile of HER2+ metastatic breast cancer managed with trastuzumab deruxtecan.

Recent Videos
Medium closeup shot of a women in front of a dark blue background with graphics that read "All in Against Cancer" and "Ochsner Health"
Smiling woman in front of a blue video call background with logos that say "All in Against Cancer" and "Ochsner Health" above her
woman in front of a dark blue background for Oschner Health
woman in front of a blue background with dark hair
image of a woman in front of a blue background with a navy top
woman with a white top sitting in front of a green wall
a man wearing a suit and tie in front of a green screen with the ONN logo
a woman sitting in front of a green wall with a white top and glasses
a woman with a white shirt and glasses sitting in front of a green wall.
Ann H. Partridge, MD, MPH, in an interview with Oncology Nursing News at 2024 ESMO Congress.
Related Content
Blue rendering of a person with breast tissue highlighted in orange

T-DM1 Further Improves DFS and OS vs Trastuzumab in HER2-Positive Early Breast Cancer

Bridget Hoyt
February 20th 2025
Article

T-DM1 reduced risk of invasive disease events and death compared with trastuzumab in HER2-positive early breast cancer with residual invasive disease after neoadjuvant therapy.

The Vitals

ctDNA Monitoring is a Piece of the Puzzle in CRC Treatment

Lindsay Fischer
October 31st 2023
Podcast

Holly Chitwood, DNP, FNP-C, AGACNP-BC, explains how circulating tumor DNA monitoring helps providers screen minimal residual disease in individuals with colorectal cancer.

Image of a three-dimensional model of a gastrointestinal tract with a stethascope surrounding it in an arc shape.

Envafolimab Plus Suvemcitug and FOLFIRI Demonstrates Early Efficacy in CRC

Kyle Doherty
February 10th 2025
Article

Envafolimab plus suvemcitug and FOLFIRI showed early efficacy and manageable safety in MSS/pMMR colorectal cancer, according to phase 2 trial data.

Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

Lindsay Fischer
October 2nd 2023
Podcast

Ryan Tamargo, NP, AONCP, discusses the launch of an online inflammatory breast cancer scoring system tool.

Blue diagram of a human's bones and tissue, with the breast tissue and tumor in focus

Pertuzumab Biosimilar BLA for HER2+ Breast Cancer Accepted by FDA

Chris Ryan
February 7th 2025
Article

After a phase 3 study showed a promising pCR rate with HLX11, the pertuzumab biosimilar’s BLA has been accepted for review by the FDA.

Illustration of a diagram of the colon with a red spot on the upper right, next to smaller illustrations of lab equipment and a clipboard

Thermal Ablation and Surgical Resection Have Similar OS in CRC Liver Metastases

Roman Fabbricatore
February 6th 2025
Article

Thermal ablation was associated with no treatment-related deaths and fewer AEs compared to surgical resection in patients with CRC liver metastases.